Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287134881> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4287134881 endingPage "67" @default.
- W4287134881 startingPage "63" @default.
- W4287134881 abstract "This study aims to describe the frequency of biologic therapy failure in psoriasis patients along with associated patient demographics and characteristics.This was a retrospective medical-record review of psoriasis patients evaluated from January 1st, 2013, through May 1st, 2018, and who failed at least once to adhere to their biologic therapy.Seventy-seven patients with psoriasis who had discontinued biologic therapy at least once were included in this study. Hypertension (58.4%), diabetes (37.7%), dyslipidemia (27.3%), and psoriatic arthritis (23.4%) were the main comorbidities observed. Adalimumab (ADA, 80.5%), ustekinumab (UST, 70.1%), and etanercept (ETA, 14.2%) were the most frequently used biologics in our cohort. The biologic with the longest mean duration of use prior to its discontinuation was UST (17.0 months), followed by ADA (15.9 months) and ETA (13.6 months).The most common reason for discontinuing biologic therapy was that said therapy was not effective, though for ETA and UST, the fact that biologic therapies are not universally covered by insurance company was found to be associated with their discontinuation, as well. There were no statistically significant associations found between biologic therapy discontinuation and age, gender, or comorbidities, which last included obesity, class I. Larger studies are warranted to identify risk factors associated with biologic therapy failure to help guide drug selection, decrease morbidity associated with such nonadherence and improve patient outcomes." @default.
- W4287134881 created "2022-07-25" @default.
- W4287134881 creator A5003709818 @default.
- W4287134881 creator A5006080374 @default.
- W4287134881 creator A5056617104 @default.
- W4287134881 creator A5060288358 @default.
- W4287134881 creator A5063186910 @default.
- W4287134881 date "2021-06-01" @default.
- W4287134881 modified "2023-09-29" @default.
- W4287134881 title "Failure of Biologic Therapy in Psoriasis." @default.
- W4287134881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34543563" @default.
- W4287134881 hasPublicationYear "2021" @default.
- W4287134881 type Work @default.
- W4287134881 citedByCount "0" @default.
- W4287134881 crossrefType "journal-article" @default.
- W4287134881 hasAuthorship W4287134881A5003709818 @default.
- W4287134881 hasAuthorship W4287134881A5006080374 @default.
- W4287134881 hasAuthorship W4287134881A5056617104 @default.
- W4287134881 hasAuthorship W4287134881A5060288358 @default.
- W4287134881 hasAuthorship W4287134881A5063186910 @default.
- W4287134881 hasConcept C126322002 @default.
- W4287134881 hasConcept C16005928 @default.
- W4287134881 hasConcept C167135981 @default.
- W4287134881 hasConcept C2776260265 @default.
- W4287134881 hasConcept C2777138892 @default.
- W4287134881 hasConcept C2777226972 @default.
- W4287134881 hasConcept C2777575956 @default.
- W4287134881 hasConcept C2778096610 @default.
- W4287134881 hasConcept C2778715236 @default.
- W4287134881 hasConcept C2778975655 @default.
- W4287134881 hasConcept C2779134260 @default.
- W4287134881 hasConcept C2780132546 @default.
- W4287134881 hasConcept C2780564577 @default.
- W4287134881 hasConcept C2781290027 @default.
- W4287134881 hasConcept C71924100 @default.
- W4287134881 hasConcept C72563966 @default.
- W4287134881 hasConceptScore W4287134881C126322002 @default.
- W4287134881 hasConceptScore W4287134881C16005928 @default.
- W4287134881 hasConceptScore W4287134881C167135981 @default.
- W4287134881 hasConceptScore W4287134881C2776260265 @default.
- W4287134881 hasConceptScore W4287134881C2777138892 @default.
- W4287134881 hasConceptScore W4287134881C2777226972 @default.
- W4287134881 hasConceptScore W4287134881C2777575956 @default.
- W4287134881 hasConceptScore W4287134881C2778096610 @default.
- W4287134881 hasConceptScore W4287134881C2778715236 @default.
- W4287134881 hasConceptScore W4287134881C2778975655 @default.
- W4287134881 hasConceptScore W4287134881C2779134260 @default.
- W4287134881 hasConceptScore W4287134881C2780132546 @default.
- W4287134881 hasConceptScore W4287134881C2780564577 @default.
- W4287134881 hasConceptScore W4287134881C2781290027 @default.
- W4287134881 hasConceptScore W4287134881C71924100 @default.
- W4287134881 hasConceptScore W4287134881C72563966 @default.
- W4287134881 hasIssue "2" @default.
- W4287134881 hasLocation W42871348811 @default.
- W4287134881 hasOpenAccess W4287134881 @default.
- W4287134881 hasPrimaryLocation W42871348811 @default.
- W4287134881 hasRelatedWork W11739056 @default.
- W4287134881 hasRelatedWork W12908628 @default.
- W4287134881 hasRelatedWork W1320415 @default.
- W4287134881 hasRelatedWork W13260057 @default.
- W4287134881 hasRelatedWork W14377470 @default.
- W4287134881 hasRelatedWork W1856643 @default.
- W4287134881 hasRelatedWork W20399346 @default.
- W4287134881 hasRelatedWork W21071975 @default.
- W4287134881 hasRelatedWork W21489353 @default.
- W4287134881 hasRelatedWork W7285742 @default.
- W4287134881 hasVolume "40" @default.
- W4287134881 isParatext "false" @default.
- W4287134881 isRetracted "false" @default.
- W4287134881 workType "article" @default.